Background and Purpose-In acute stroke, mismatch between lesions seen on diffusion-(DWI) and perfusion-weighted (PWI) MRI has been used to identify ischemic tissue before irreversible damage. Nevertheless, the concept of PWI/DWI mismatch is oversimplified and the ischemic tissue metabolic status and outcome are often heterogeneous. Tissue pH, a well-regulated physiological index that alters on disrupted tissue metabolism, may provide a surrogate metabolic imaging marker that augments the DWI and PWI for penumbra imaging. Methods-pH-weighted MRI was obtained by probing the pH-dependent amide proton transfer between endogenous mobile proteins/peptides and tissue water. The technique was validated using animal stroke models, optimized for human use, and preliminarily tested for imaging healthy volunteers. Results-pH-weighted MRI is sensitive and specific to ischemic tissue acidosis. pH MRI can be optimized for clinical use, and a pilot human study showed it is feasible using a standard 3 Tesla MRI scanner. Conclusions-Ischemic acidosis can be imaged via an endogenous pH-weighted MRI technique, which complements conventional PWI and DWI for penumbra imaging. pH-weighted MRI has been optimized and appears feasible and practical in imaging human subjects. Additional study is necessary to elucidate the diagnostic use of pH MRI in stroke patients. (Stroke. 2010;41[suppl 1]:S147-S151.)
T he development of diffusion and perfusion MRI has improved our understanding of acute ischemic tissue damage, and is increasingly used to help guide stroke treatment. [1] [2] [3] Specifically, while thrombolytic therapy can restore blood flow and improve patient outcome, the clinic usage of tissue plasminogen activator (tPA) is still limited due to its narrow 3-hour (or, in some locations, 4.5 hour) treatment window. 4 -8 One approach to overcoming this problem is to develop noninvasive penumbra imaging that might identify patients who may potentially benefit from late tPA treatment with minimal adverse effects. 9 -14 Because ischemic tissue damage is heterogeneous, salvageable ischemic penumbral tissue may be present well beyond the conventional tPA treatment window. 15 Perfusion-weighted (PWI) and diffusionweighted (DWI) MRI are the most well-established imaging techniques being used to detect regions of reduced blood flow and cytotoxic edema, respectively. 16, 17 As such, the PWI/DWI mismatch is postulated to represent ischemic tissue that has not yet undergone severe tissue damage, and sometimes used operationally to define the ischemic penumbra. 1, 18, 19 Whereas the PWI/DWI mismatch provides important pathophysiological insight and can be readily identified, ischemic tissue damage is complex and multifactorial, and the PWI/DWI mismatch provides only an approximation of the penumbra. 20, 21 It has been observed that the final infarct volume is generally smaller than the initial PWI lesion, yet larger than the acute DWI lesion. In addition, the DWI abnormality is energetically heterogeneous and portions of some DWI lesions may reverse if treated promptly. [22] [23] [24] Hence, despite being the most practical method at the present, the concept of PWI/DWI mismatch may be somewhat oversimplified. New imaging markers could augment existing penumbral imaging and provide greater insight into disease pathophysiology and perhaps, if validated, serve to help guide treatment decisions such as late thrombolysis.
As energy production is vital for cell viability, monitoring tissue metabolism may offer additional insights about ischemic tissue damage and outcome. 10 It has been shown that cerebral oxygen and glucose metabolism are disrupted at blood flow levels higher than those that cause infarction, and therefore, measurement of oxygen and/or glucose metabolism may provide a sensitive index of early ischemia before irreversible damage. Specifically, in ischemic tissue lactic acid is produced because of anaerobic glycolysis, causing tissue acidosis (decreased pH). 25 The cellular energy imbalance is exacerbated because of the reduced buffering capacity of bicarbonate at acidic pH, hypoperfusion, and disrupted oxygen and glucose metabolism; hence, tissue pH may fall even further. As a result, essential ATP-dependent functions such as the critical enzyme Na/K-ATPase are compromised, and without prompt treatment, ischemia will eventually lead to cell death and irreversible tissue damage. Therefore, tissue pH imaging may serve as an important physiological biomarker for tissue viability and dysfunction, complementing the conventional hemodynamic and structurally based MRI. However, historically, noninvasive in vivo pH imaging has been quite challenging. While 31 P and lactate magnetic resonance spectroscopy (MRS) may reflect tissue metabolic state and therefore have been actively investigated, their sensitivity and spatiotemporal resolution are not yet adequate for imaging acute stroke. 26 To address this unmet biomedical need, chemical exchange saturation transfer (CEST)-based pH MRI has been recently developed. 27, 28 As CEST MRI probes pH via the abundant tissue water signal, its pH sensitivity is significantly higher than that of the conventional MRS-based methods, and remains promising for in vivo use. Amide proton transfer imaging, a specific form of CEST MRI that uses the composite amide protons from endogenous mobile proteins and peptides, is particularly suitable for in vivo pH imaging. 29, 30 Specifically, endogenous amide proton exchange is dominantly base-catalyzed, and its exchange rate, and hence pH MRI signal, decreases at the acidic pH present during ischemia. Our preclinical animal stroke studies have demonstrated that pH MRI deficit detects not only tissue that's abnormal on DWI, but also additional hypoperfused tissue with altered oxygen metabolism, strongly suggesting that it may serve as a novel metabolic imaging marker for the ischemic penumbra that does not require injection of an exogenous contrast agent. 31 These observations highlight the potential value of performing pH imaging in acute stroke patients. Toward this goal, we have optimized an in vivo pH-weighted MRI protocol and developed necessary image processing tools, and preliminarily tested the pH-weighted MRI at 3 Tesla. 32 Here, we describe this methodology and present pilot human pH imaging.
Materials and Methods

Animal Model
Animal studies were conducted following an institutionally approved protocol. Adult male Wister rats (Charles River, Wilmington, Mass) were anesthetized using the isoflurance regimen (1% to 1.5% during study, 70% N 2 O/30% O 2 ) and had standard physiological monitoring throughout the study. Global ischemia was induced in 3 animals via KCl injection through the femoral artery, and an additional 4 animals were subjected to filament middle cerebral artery occlusion.
Healthy Volunteer
All studies were approved by our institutional review board (IRB). A healthy male volunteer aged 34 years was scanned at 3 Tesla, and consent forms were obtained before the study.
Magnetic Resonance Imaging
Animals were imaged using a Bruker 4.7T scanner. The pHweighted MRI includes continuous wave saturation before single slice spin echo echo planar imaging readout (slice thickness of 2.5 mm). The image matrix was 64ϫ64, with an isotropic in-plane resolution of 0.5 mm. The repetition time and echo time were TR/TEϭ6500 ms/32 ms, and 16 signal averages (number of average [NA]) were obtained. The irradiation radiofrequency (RF) amplitude was 0.75 T (Ϸ30 Hz) with offset varied serially from Ϫ6 to 6 ppm per 0.5 ppm. In addition, standard T 1 , T 2 , and diffusion images were acquired. For the global ischemia model, MRI was acquired both before and immediately after cardiac arrest. For the focal ischemia model, point resolved solvent suppressed spectroscopy (PRESS) MRS was also performed, with 2 regions of interest of 4 mm 3 each positioned in the ipsilateral ischemic lesion and contralateral normal areas (TR/TEϭ1000 ms/144 ms, and NAϭ1024).
Clinical implementation was done on a 3T Siemens Tim Trio scanner (Siemens), using a 32-channel RF receiver head coil. RF irradiation was composed of a train of pulses, each with a duration of 20 ms with an interval of 20 ms delay (50% duty cycle), interleaved between single shot echo planar imaging readout. We used TR/TEϭ5000 ms/12 ms, NAϭ4 and the total scan time was 2.5 minutes. The RF offsets were Ϫ3.5, 2, 2.75, 3.5, 4.25 and 5 ppm. In addition, standard field mapping was acquired (TRϭ100 ms, ⌬TEϭ2.46 ms), with a scan time of 12 s. Eight slices were acquired and each slice thickness was 6 mm, distance factor of 25%. The field of view was 192ϫ192 mm with image matrix being 64ϫ64, for both pH MRI and field map to facilitate coregistration, and zero-filled to 128ϫ128. Motion artifact was corrected using the standard motion correction FMRIBs linear image registration tool (MCFLIRT). 33, 34 Results Figure 1 shows that the pH-weighted MRI measurements changed noticeably on global ischemia. Specifically, Figure 1 . Evaluation of in vivo pH-weighted MRI intensity. Z-spectra were acquired shortly before and immediately after postmortem, which showed signal increase around 3.5 ppm, the composite amide proton chemical shift (a). The difference of Z-spectra clearly showed pH-induced decrease of exchange rate, consistent with the fact the amide proton exchange is dominantly based catalyzed (b).
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Z-spectrum was obtained by monitoring tissue water signal while the RF irradiation was swept around water resonance. While this technique is similar to magnetization transfer (MT) MRI, it is important to note that its RF irradiation has been optimized for sensitizing proton exchange of endogenous proteins/peptides. 30 Notably, the magnetization transfer ratio (MTR) was 68.6Ϯ1.1% under normal conditions, and increased to 72.4Ϯ0.4% postmortem, consistent with the notion that endogenous amide proton exchange is dominantly base-catalyzed around physiological pH (Figure 1a) . The maximal change in Z-spectral intensity was 3.8% peaked at 3.5 ppm, representing the composite amide proton chemical shift (Figure 1b) . This suggested that tissue pH can be assessed via the pH-weighted CEST/amide proton transfer MRI. In addition, the apparent diffusion coefficient decreased from 0.84Ϯ0.01 to 0.61Ϯ0.02 m 2 /ms. In addition, T 1 and T 2 changed from 1.41Ϯ0.03 s and 58.8Ϯ0.7 ms to 1.36Ϯ0.13 s and 56.3Ϯ0.9 ms, respectively, likely attributable to the slightly decreased body temperature and edema during global ischemia.
We also preliminarily compared pH-weighted MRI with lactate MRS using the focal ischemia animal model. The pH-weighted MRI was calculated as MTR asymmetry, (ie, I ref ϪI label /I 0 ), where I ref and T label are reference and label with RF applied at -3.5 and 3.5 ppm, respectively, and I 0 is the scan without RF irradiation. The pH MRI showed a large pH deficit across the hypoperfused right MCA territory (Figure 2a) . In addition, the MRS showed that the lactate level in the ipsilateral stroke lesion was greatly elevated, but lactate was nearly absent in the contralateral normal region, similar to the findings of Jokivarsi et al 35 (Figure 2b ). Moreover, a subtle N-acetylaspartate decrease was observed, consistent with early neuronal damage during acute ischemia. Figure 3 shows a pilot pH-weighted MRI of a normal volunteer. It is important to point out that the field inhomogeneity was compensated based on the coregistered field map. In addition, the pH-weighted image was calculated by taking the difference between the label scan (3.5 ppm) and mean of 2 reference scans (2 and 5 ppm) instead of the commonly used MTR asymmetry analysis. This alternative method was significantly less susceptible to the intrinsic MTR asymmetry shift. The pH-weighted MRI appeared reasonably homogeneous within the brain, which should facilitate detection of subtle pH lesions in acute stroke patients.
Discussion
Our work confirms reports of preclinical pH-weighted MRI. 31 We extend earlier work by translating this method to the clinical setting, and obtained promising pilot data from a healthy volunteer. Given that pH is well regulated under normal physiological conditions, it may serve as a specific surrogate biomarker for altered tissue metabolism, particularly useful for characterizing heterogeneous ischemic tissue damage. Our preclinical study showed that abnormalities detected on pH-MRI correlate with much of the PWI/DWI mismatch. 31 While these preclinical studies have been crucial to verify the methodology, considerable effort has been required for clinical translation. Specifically, we have optimized the image acquisition and processing, including optimizing the pulsed-RF irradiation, 
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correcting motion and field inhomogeneity artifacts, and compensating the concomitant intrinsic MTR asymmetry shift. 36 The scan time has been significantly reduced so that patients may be imaged with only minimal or no interference with their clinical care. It is important to point out that additional fast multi-slice pH MRI pulse sequence and image processing algorithms are currently being evaluated, which may further facilitate routine clinic use of pH MRI. For instance, tissue pH MRI may serve as an imaging metabolic biomarker for guiding late thrombolytic treatment and evaluating novel therapeutics that aims to improve tissue metabolism. 37 Our study used the endogenous amide proton signal and provided only pH-weighted information. However, pHweighted MRI contrast could change slightly in the presence of changes in relaxation times, such as in the setting of vasogenic edema. Although such issues are presumably not a major problem for hyperacute stroke patients, these confounds might be present in the setting of subacute or chronic ischemia. In addition, our current study used reference images around the composite amide proton offset instead of the conventional reference scan at Ϫ3.5 ppm to minimize concomitant MT asymmetry effect. In summary, our goal is to fully develop pH MRI and evaluate its diagnostic utility in clinic, and ultimately to augment our diagnostic capability of stroke and other debilitating diseases.
Summary
Our study demonstrated a noninvasive endogenous pHweighted MRI technique in an animal model of cerebral ischemia, and translated it to initial human use. This work confirms that pH-weighted MRI is feasible in the clinic, which may ultimately provide complementary information to the routine PWI and DWI scans. Additional study is needed to test whether pH MRI may augment routine clinical MRI and ultimately help guide stroke treatment.
